[1] C. De Weerth, S. Fuentes, P. Puylaert, and W. M. De Vos, “Intestinal microbiota of infants with colic: Development and specific signatures,” Pediatrics, vol. 131, no. 2, 2013, doi: 10.1542/peds.2012-1449.
[2] K. Korpela et al., “Microbiome of the first stool after birth and infantile colic,” Pediatr. Res., vol. 88, no. 5, pp. 776–783, 2020, doi: 10.1038/s41390-020-0804-y.
[3] J. G. de Moraes, M. E. F. de A. Motta, M. F. de S. Beltrão, T. L. Salviano, and G. A. P. da Silva, “Fecal Microbiota and Diet of Children with Chronic Constipation,” Int. J. Pediatr., vol. 2016, pp. 1–8, 2016, doi: 10.1155/2016/6787269.
[4] X. Ye, F. Yu, J. Zhou, C. Zhao, J. Wu, and X. Ni, “Analysis of the gut microbiota in children with gastroesophageal reflux disease using metagenomics and metabolomics,” Front. Cell. Infect. Microbiol., vol. 13, no. October, pp. 1–13, 2023, doi: 10.3389/fcimb.2023.1267192.
[5] H. Wopereis, K. Sim, A. Shaw, J. O. Warner, J. Knol, and J. S. Kroll, “Intestinal microbiota in infants at high risk for allergy: Effects of prebiotics and role in eczema development,” J. Allergy Clin. Immunol., vol. 141, no. 4, pp. 1334-1342.e5, 2018, doi: 10.1016/j.jaci.2017.05.054.
[6] T. Feehley, C. H. Plunkett, R. Bao, and S. M. C. Hong, “Healthy infants harbor intestinal bacteria that protect against food allergy,” Nat Med., vol. 25, no. 3, pp. 448–453, 2019, doi: 10.1038/s41591-018-0324-z.
[7] B. Cukrowska, J. B. Bierła, M. Zakrzewska, M. Klukowski, and E. Maciorkowska, “The relationship between the infant gut microbiota and allergy. The role of Bifidobacterium breve and prebiotic oligosaccharides in the activation of anti-allergic mechanisms in early life,” Nutrients, vol. 12, no. 4, 2020, doi: 10.3390/nu12040946.
[8] M. C. Arrieta et al., “Early infancy microbial and metabolic alterations affect risk of childhood asthma,” Sci. Transl. Med., vol. 7, no. 307, 2015, doi: 10.1126/scitranslmed.aab2271.
[9] M. Kalliomäki, M. C. Collado, S. Salminen, and E. Isolauri, “Early differences in fecal microbiota composition in children may predict overweight,” Am. J. Clin. Nutr., vol. 87, no. 3, pp. 534–538, 2008, doi: 10.1093/ajcn/87.3.534.
[10] K. Korpela and W. M. de Vos, “Infant gut microbiota restoration: state of the art,” Gut Microbes, vol. 14, no. 1, pp. 1–14, 2022, doi: 10.1080/19490976.2022.2118811.
[11] R. C. Robertson, A. R. Manges, B. B. Finlay, and A. J. Prendergast, “The Human Microbiome and Child Growth – First 1000 Days and Beyond,” Trends Microbiol., vol. 27, no. 2, pp. 131–147, 2019, doi: 10.1016/j.tim.2018.09.008.
[12] V. B. Young and T. M. Schmidt, “Overview of the gastrointestinal microbiota,” Adv. Exp. Med. Biol., vol. 635, pp. 29–40, 2008, doi: 10.1007/978-0-387-09550-9_3.
[13] C. A. Lozupone, J. I. Stombaugh, J. I. Gordon, J. K. Jansson, and R. Knight, “Diversity, stability and resilience of the human gut microbiota,” Nature, vol. 489, no. 7415, pp. 220–230, 2012, doi: 10.1038/nature11550.
[14] E. Le Chatelier et al., “Richness of human gut microbiome correlates with metabolic markers,” Nature, vol. 500, no. 7464, pp. 541–546, 2013, doi: 10.1038/nature12506.
[15] C. Milani et al., “The First Microbial Colonizers of the Human Gut : Composition, Activities, and Health Implications of the Infant Gut Microbiota,” Microbiol. Mol. Biol. Rev., vol. 81, no. 4, pp. 1–67, 2017.
[16] M. Derrien, A. S. Alvarez, and W. M. de Vos, “The Gut Microbiota in the First Decade of Life,” Trends Microbiol., vol. 27, no. 12, pp. 997–1010, 2019, doi: 10.1016/j.tim.2019.08.001.
[17] N. A. Bokulich, J. Chung, T. Battaglia, and N. Henderson, “Antibiotics, birth mode, and diet shape microbiome maturation during early life,” Sci Transl Med., vol. 8, no. 343, pp. 1–25, 2016, doi: 10.1126/scitranslmed.aad7121.
[18] C. Hidalgo-Cantabrana, S. Delgado, L. Ruiz, P. Ruas-Madiedo, B. Sánchez, and A. Margolles, “Bifidobacteria and Their Health-Promoting Effect,” Microbiol. Spectr., vol. 5, no. 3, pp. 1–19, 2017, doi: 10.1128/microbiolspec.BAD-0010-2016.
[19] B. M. Henrick et al., “Bifidobacteria-mediated immune system imprinting early in life,” Cell, vol. 184, no. 15, pp. 3884-3898.e11, 2021, doi: 10.1016/j.cell.2021.05.030.
[20] A. Marcobal and J. L. Sonnenburg, “Human milk oligosaccharide consumption by intestinal microbiota,” Clin. Microbiol. Infect., vol. 18, no. SUPPL. 4, pp. 12–15, 2012, doi: 10.1111/j.1469-0691.2012.03863.x.
[21] C. Walsh, J. A. Lane, D. Van Sinderen, and R. M. Hickey, “Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health,” J. Funct. Foods, vol. 72, no. January, 2020, doi: https://doi.org/10.1016/j.jff.2020.104074.
[22] M. A. Underwood, S. Mukhopadhyay, S. Lakshminrusimha, and C. L. Bevins, “Neonatal intestinal dysbiosis,” J. Perinatol., vol. 40, no. 11, pp. 1597–1608, 2020, doi: 10.1038/s41372-020-00829-2.
[23] A. Loughman et al., “Infant microbiota in colic: Predictive associations with problem crying and subsequent child behavior,” J. Dev. Orig. Health Dis., vol. 12, no. 2, pp. 260–270, 2021, doi: 10.1017/S2040174420000227.
[24] H. H. Chua et al., “Intestinal Dysbiosis Featuring Abundance of Ruminococcus gnavus Associates With Allergic Diseases in Infants,” Gastroenterology, vol. 154, no. 1, pp. 154–167, 2018, doi: 10.1053/j.gastro.2017.09.006.
[25] R. F. Lamont, B. M. Luef, and J. S. Jørgensen, “Childhood inflammatory and metabolic disease following exposure to antibiotics in pregnancy, antenatally, intrapartum and neonatally,” F1000Research, vol. 9, pp. 1–10, 2020, doi: 10.12688/f1000research.19954.1.
[26] Q. Fan et al., “The impact of age and pathogens type on the gut microbiota in infants with diarrhea in Dalian, China,” Can. J. Infect. Dis. Med. Microbiol., vol. 2020, 2020, doi: 10.1155/2020/8837156.
[27] M. R. Olm et al., “Necrotizing enterocolitis is preceded by increased gut bacterial replication, Klebsiella, and fimbriae-encoding bacteria,” Sci. Adv., vol. 5, no. 12, pp. 1–12, 2019, doi: 10.1126/sciadv.aax5727.
[28] S. Michail, M. Durbin, D. Turner, and A. M. Griffiths, “Alterations in the gut microbiome of children with severe ulcerative colitis,” Inflamm Bowel Dis., vol. 18, no. 10, pp. 1799–1808, 2012, doi: doi:10.1002/ibd.22860.
[29] T. Vatanen et al., “The human gut microbiome in early-onset type 1 diabetes from the TEDDY study,” Nature, vol. 562, no. 7728, pp. 589–594, 2018, doi: 10.1038/s41586-018-0620-2.
[30] S. Rampelli et al., “Pre-obese children’s dysbiotic gut microbiome and unhealthy diets may predict the development of obesity,” Commun. Biol., vol. 1, no. 1, 2018, doi: 10.1038/s42003-018-0221-5.
[31] K. Korpela et al., “Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children,” Nat. Commun., vol. 7, 2016, doi: 10.1038/ncomms10410.
[32] A. Uzan-Yulzari et al., “Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization,” Nat. Commun., vol. 12, no. 1, 2021, doi: 10.1038/s41467-020-20495-4.
[33] M. G. Dominguez-Bello et al., “Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns,” Proc. Natl. Acad. Sci. U. S. A., vol. 107, no. 26, pp. 11971–11975, 2010, doi: 10.1073/pnas.1002601107.
[34] G. Biasucci, M. Rubini, S. Riboni, L. Morelli, E. Bessi, and C. Retetangos, “Mode of delivery affects the bacterial community in the newborn gut,” Early Hum. Dev., vol. 86, no. SUPPL. 1, pp. 13–15, 2010, doi: 10.1016/j.earlhumdev.2010.01.004.
[35] R. Martin et al., “Early-Life events, including mode of delivery and type of feeding, siblings and gender, shape the developing gut microbiota,” PLoS One, vol. 11, no. 6, pp. 1–30, 2016, doi: 10.1371/journal.pone.0158498.